Imunon, Inc. financial data

Symbol
IMNN on Nasdaq
Industry
Pharmaceutical Preparations
Location
997 Lenox Drive, Suite 100, Lawrenceville, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
CELSION CORP (to 9/19/2022), Celsion CORP (to 9/19/2022), CHEUNG LABORATORIES INC (to 2/17/1998)
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 200 % -43.2%
Debt-to-equity 95 % +100%
Return On Equity -302 % -208%
Return On Assets -155 % -133%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.6M shares +55.5%
Common Stock, Shares, Outstanding 14.5M shares +54.3%
Entity Public Float 10.8M USD -9.24%
Common Stock, Value, Issued 145K USD +54.3%
Weighted Average Number of Shares Outstanding, Basic 11.5M shares +27.2%
Weighted Average Number of Shares Outstanding, Diluted 11.5M shares +27.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11.6M USD +3.12%
General and Administrative Expense 7.49M USD -23.1%
Operating Income (Loss) -19.1M USD +9.03%
Nonoperating Income (Expense) 512K USD +118%
Net Income (Loss) Attributable to Parent -18.6M USD +4.59%
Earnings Per Share, Basic -1.62 USD/shares +25%
Earnings Per Share, Diluted -1.62 USD/shares +25%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.87M USD +0.59%
Cash, Cash Equivalents, and Short-term Investments 5.9M USD -62.4%
Assets, Current 8.01M USD -56.1%
Other Long-term Investments 3.75M USD -37.5%
Deferred Income Tax Assets, Net 1.28M USD -18.3%
Property, Plant and Equipment, Net 541K USD -28%
Operating Lease, Right-of-Use Asset 1.12M USD -30%
Other Assets, Noncurrent 1.17M USD -60.1%
Assets 9.72M USD -55.7%
Accounts Payable, Current 3.52M USD -1.99%
Employee-related Liabilities, Current 1.95M USD +14.9%
Accrued Liabilities, Current 3.03M USD -10.5%
Liabilities, Current 4.79M USD -35.2%
Operating Lease, Liability, Noncurrent 687K USD -39.7%
Liabilities 5.47M USD -35.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 133K USD +7.45%
Retained Earnings (Accumulated Deficit) -407M USD -4.8%
Stockholders' Equity Attributable to Parent 4.24M USD -68.3%
Liabilities and Equity 9.72M USD -55.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.87M USD -47.5%
Net Cash Provided by (Used in) Financing Activities 2.47M USD
Net Cash Provided by (Used in) Investing Activities 2.38M USD +472%
Common Stock, Shares Authorized 113M shares 0%
Common Stock, Shares, Issued 14.5M shares +54.3%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.49M USD -220%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.84M USD -66.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 180K USD -95.7%
Deferred Tax Assets, Valuation Allowance 74.6M USD +2.27%
Deferred Tax Assets, Gross 74.6M USD +0.51%
Operating Lease, Liability 1.14M USD -29.9%
Depreciation 70.3K USD +42%
Payments to Acquire Property, Plant, and Equipment 11.8K USD -79.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -18.6M USD +4.42%
Lessee, Operating Lease, Liability, to be Paid 1.31M USD -32.4%
Property, Plant and Equipment, Gross 1.74M USD -39.1%
Operating Lease, Liability, Current 452K USD -6.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 363K USD -33.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 543K USD -13.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 1.28M USD -18.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 168K USD -45.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 370K USD +2%
Deferred Tax Assets, Operating Loss Carryforwards 66.1M USD -1.74%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100K shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 370K USD
Operating Lease, Payments 660K USD +2.34%
Additional Paid in Capital 411M USD +2.36%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 193K USD +10.7%
Deferred Tax Assets, Net of Valuation Allowance 1.28M USD -18.3%
Interest Expense 37.1K USD -64.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%